Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.11 CAD | +4.32% | +10.44% | +11.10% |
12-30 | Pfizer Ends Sangamo Partnership for Hemophilia Therapy | DJ |
11-06 | Sangoma Technologies Corporation, Q1 2025 Earnings Call, Nov 06, 2024 |
Capitalization | 262M 252M 238M 213M 375M 22.56B 418M 2.89B 1.07B 9.31B 981M 961M 40.73B | P/E ratio 2025 * |
-163x | P/E ratio 2026 * | 64.7x |
---|---|---|---|---|---|
Enterprise value | 293M 281M 266M 238M 419M 25.22B 467M 3.23B 1.2B 10.4B 1.1B 1.07B 45.54B | EV / Sales 2025 * |
1.16x | EV / Sales 2026 * | 0.96x |
Free-Float |
72.25% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Sangoma Technologies Corporation
1 day | +4.32% | ||
1 week | +10.44% | ||
Current month | +11.10% | ||
1 month | +11.10% | ||
3 months | +39.22% | ||
6 months | +70.14% | ||
Current year | +11.10% |
Director | Title | Age | Since |
---|---|---|---|
Charles Salameh
CEO | Chief Executive Officer | - | 2023-08-31 |
Larry Stock
DFI | Director of Finance/CFO | - | 2022-10-02 |
Jeremy Wubs
COO | Chief Operating Officer | - | 2023-09-10 |
Manager | Title | Age | Since |
---|---|---|---|
Al Guarino
BRD | Director/Board Member | 69 | 2014-05-22 |
Allan Brett
BRD | Director/Board Member | 57 | 2016-12-31 |
Marc Lederman
BRD | Director/Board Member | 54 | 2021-02-28 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+4.32% | +10.44% | +185.60% | -43.11% | 262M | ||
+0.69% | +2.50% | +17.48% | +3.70% | 240B | ||
+1.54% | +6.49% | +82.08% | +293.47% | 151B | ||
+0.47% | +1.77% | +42.47% | +94.62% | 77.69B | ||
+0.53% | +5.32% | +46.27% | +76.47% | 56.52B | ||
+0.53% | +3.48% | +71.90% | +74.95% | 41.42B | ||
+0.28% | +2.20% | -10.73% | -43.16% | 35.76B | ||
-0.23% | +6.05% | +54.20% | -9.27% | 28.73B | ||
-1.89% | +3.82% | +70.13% | +19.02% | 24.84B | ||
-1.00% | +12.19% | +224.04% | +41.23% | 24.59B | ||
Average | +0.52% | +4.06% | +78.34% | +50.79% | 68.08B | |
Weighted average by Cap. | +0.62% | +3.13% | +49.88% | +87.66% |
2025 * | 2026 * | |
---|---|---|
Net sales | 252M 243M 229M 205M 362M 21.77B 403M 2.78B 1.03B 8.98B 947M 927M 39.3B | 272M 261M 247M 221M 389M 23.43B 434M 3B 1.11B 9.67B 1.02B 998M 42.3B |
Net income | -825K -793K -749K -671K -1.18M -71.12M -1.32M -9.1M -3.37M -29.34M -3.09M -3.03M -128M | 3.6M 3.46M 3.27M 2.93M 5.15M 310M 5.75M 39.71M 14.71M 128M 13.5M 13.22M 560M |
Net Debt | 30.9M 29.71M 28.05M 25.12M 44.25M 2.66B 49.34M 341M 126M 1.1B 116M 114M 4.81B | -1.7M -1.63M -1.54M -1.38M -2.43M -147M -2.71M -18.75M -6.95M -60.46M -6.38M -6.24M -265M |
Date | Price | Change | Volume |
---|---|---|---|
25-01-20 | 11.11 $ | +4.32% | 11,412 |
25-01-17 | 10.65 $ | +1.24% | 11,892 |
25-01-16 | 10.52 $ | +2.24% | 51,430 |
25-01-15 | 10.29 $ | +2.80% | 48,338 |
25-01-14 | 10.01 $ | -0.50% | 15,949 |
Delayed Quote Toronto S.E., January 20, 2025 at 03:59 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- STC Stock
MarketScreener is also available in this country: United States.
Switch edition